Vitamin D in winter: should you take it in Belgium? What the studies really say

Vitamin D in winter: should you take it in Belgium? What the studies really say

In short: in Belgium, the winter sun is too low for the skin to make a useful amount of vitamin D, roughly from late October to early March. An ordinary diet provides only a small part of what is needed. The Belgian Superior Health Council recommends 10 µg (400 IU) a day for an adult and 20 µg (800 IU) over the age of 70 or during pregnancy. Vitamin D is essential for the bones. However, the large trials carried out in the general population, in adults who were mostly not deficient, showed no benefit on cancer, the heart, depression or mortality.

Why vitamin D levels drop in winter

Vitamin D has a special feature: our body can make it itself, as long as the skin receives ultraviolet B (UVB) rays. UVB converts a cholesterol derivative in the skin into vitamin D3, which the liver and then the kidneys turn into the active form. The form stored by the liver, 25-hydroxyvitamin D, or 25(OH)D, is what a blood test measures.

The problem is the angle of the sun. In winter, the rays pass through a much thicker layer of atmosphere, and almost all UVB is filtered out before it reaches the ground. A landmark study measured this production directly: in Boston (42° north), sunlight on cloudless days no longer triggered any production from November to February; in Edmonton, Canada (52° north), from October to March (Webb et al., 1988). Brussels lies at about 51° north, much closer to Edmonton than to Boston.

In practice, a sunny walk at noon in January is good for your mood, but not for your vitamin D level. The body then lives on the reserves built up over the summer, and these reserves fall month after month. This is why the lowest levels are usually seen at the end of winter and the beginning of spring.

How much do you need? The Belgian benchmarks

In Belgium, recommended intakes are set by the Superior Health Council (SHC). The values quoted by Sciensano in the 2022-2023 national food consumption survey are as follows (Sciensano, 2025a):

Group Recommended intake per day
Children 10 µg (400 IU)
Adults 10 µg (400 IU)
Adults at risk of osteoporosis 15 µg (600 IU)
Over 70 20 µg (800 IU)
Pregnancy and breastfeeding 20 µg (800 IU)

A word on units: 1 µg (microgram) of vitamin D equals 40 international units (IU). Supplement packs often show both.

A small source of confusion: another Sciensano page on vitamin D gives 15 µg a day for adults (Sciensano, 2025b), while the page on supplement use and the Belgian Nutrition Information Center give 10 µg, or 15 µg for people at risk of osteoporosis (NICE, 2020). Either way, these are modest amounts, nothing like the high-dose ampoules sold in pharmacies.

There is also an upper limit. In 2023, the European Food Safety Authority (EFSA) set it at 100 µg (4,000 IU) a day for adults, including during pregnancy and breastfeeding, and for adolescents aged 11 to 17, and at 50 µg (2,000 IU) a day for children aged 1 to 10 (EFSA, 2023). This is not a recommended dose but a ceiling not to be exceeded over time, even when combining several products.

How are Belgians doing?

The Sciensano survey gives a fairly precise picture (Sciensano, 2025a, 2025b):

  • from food alone, average intake is only 5 µg a day; with supplements, it rises to 15 µg;
  • 28% of Belgians aged 3 and over take a vitamin D supplement, up from 19% in 2014-2015;
  • this is the case for 48% of women and 30% of men over 65;
  • use is higher in Wallonia (37%) than in Flanders (27%);
  • among users, 34% take the highest dose, 25,000 IU (625 µg) per intake, a common strength for ampoules sold in pharmacies;
  • 2% of the population is at risk of exceeding the safety limit, always because of supplements, never from food alone.

Data on blood levels themselves are scarcer. A study in Brussels of 401 adults aged 40 to 60 found that 77% had a level below 50 nmol/L (20 ng/mL), and 34% below 25 nmol/L (10 ng/mL), with large differences depending on the participants' origin and the season of the blood sample (Moreno-Reyes et al., 2009). It is a single, fairly old study carried out in one city: it does not apply to the whole Belgian population, but it shows that low levels are not rare at our latitude.

Is food enough?

Rarely. Very few foods naturally contain useful amounts of vitamin D. Here are some orders of magnitude from the tables of the US National Institutes of Health (National Institutes of Health, 2026):

Food Vitamin D
Farmed trout, cooked (85 g) 16.2 µg (645 IU)
Sockeye salmon, cooked (85 g) 14.2 µg (570 IU)
Cod liver oil (1 tablespoon) 34 µg (1,360 IU)
Canned sardines (2 sardines) 1.2 µg (46 IU)
Egg (1 large) 1.1 µg (44 IU)

A portion of oily fish therefore covers one or two days' intake on its own, but most of us do not eat it every day. The rest of the plate (meat, dairy, fats, eggs) only provides small amounts, which explains the Belgian average of 5 µg a day. Contents also vary a lot by species, farming and preparation: these figures are guides, not guarantees.

What vitamin D really does

Its best-established role concerns the bones. Vitamin D allows the gut to absorb calcium and phosphorus. Severe, prolonged deficiency causes rickets in children (soft, deformed bones) and osteomalacia in adults (bone pain, muscle weakness). This link is not in dispute.

For the rest, two types of studies need to be distinguished:

  • observational studies compare people who naturally have high or low levels. They often find that a low level goes hand in hand with more disease. But a low level can also be a consequence of illness, or a sign of someone who goes out little, moves little or eats less well;
  • randomised controlled trials draw lots to decide who receives vitamin D and who receives a placebo. These are what tell us whether vitamin D itself has an effect.

This is where the image of the "miracle vitamin" has been considerably toned down in recent years.

What the large trials showed (and did not show)

Several very large trials have tested vitamin D in the general population, in adults who had not been selected for deficiency and who, for the most part, were not deficient:

Trial Participants Dose Result
VITAL, cancer and heart (Manson et al., 2019) 25,871 adults over 50-55, United States, followed for 5.3 years 2,000 IU a day No reduction in invasive cancer, heart attacks or strokes. A reduction in cancer deaths was suggested, but was not statistically significant.
VITAL, fractures (LeBoff et al., 2022) Same participants 2,000 IU a day No reduction in fractures, including hip fractures.
VITAL, depression (Okereke et al., 2020) 18,353 adults aged 50 and over 2,000 IU a day No reduction in the risk of depression, and no effect on mood.
VITAL, autoimmune diseases (Hahn et al., 2022), ancillary study 25,871 adults 2,000 IU a day 22% fewer autoimmune diseases, all diseases combined (rheumatoid arthritis, psoriasis, autoimmune thyroid disease…), at the limit of statistical significance.
D-Health (Neale et al., 2022) 21,315 Australians aged 60 to 79, followed for 5.7 years 60,000 IU once a month No effect on all-cause mortality.

For respiratory infections (colds, flu, bronchitis), the most recent review pools 64 trials and more than 64,000 participants. It finds a very small, non-significant protective effect: the risk of respiratory infection falls by about 6% on average, with a margin of uncertainty ranging from a 12% reduction to no effect at all (Jolliffe et al., 2025).

The level of evidence is therefore high, since these are large randomised trials. Their message is clear: in healthy adults with no known deficiency, taking extra vitamin D showed no benefit against cancer, cardiovascular disease, fractures or depression, and did not reduce mortality, at the doses and over the periods tested. The only favourable signal, on autoimmune diseases, comes from an ancillary study and remains to be confirmed.

These trials mainly involved healthy adults without deficiency. They do not say that correcting a real deficiency is useless, but that adding more when you already have enough has no proven benefit.

What about the "anti-ageing" promises? You sometimes read that vitamin D lengthens telomeres or slows the biological clock. These claims rest on observational studies or laboratory markers, not on trials showing an effect on health. The D-Health trial, designed precisely to measure mortality, found no reduction in deaths.

Who should consider it this winter?

Recommendations converge on a few groups for whom regular supplementation makes sense, especially during the winter months:

  • people over 70, especially if they rarely go out or live in a care home;
  • pregnant or breastfeeding women;
  • babies and children, as advised by the paediatrician or by ONE / Kind en Gezin (the Belgian child health services);
  • people with dark skin, who make less vitamin D for the same sun exposure, and those who keep their skin covered at all times;
  • people at risk of osteoporosis or who have already had a fragility fracture;
  • people with a condition that impairs intestinal absorption (coeliac disease, Crohn's disease, obesity surgery…), who need medical follow-up.

This is also the position of the Endocrine Society, which published new guidelines in 2024. It advises an intake above the usual recommended amounts for children and adolescents, people over 75, pregnant women and adults with high-risk prediabetes. On the other hand, it advises against exceeding the usual amounts in healthy adults under 75 (Demay et al., 2024).

Should you have a blood test?

Not routinely. The Endocrine Society guidelines advise against routine 25(OH)D testing in people without a particular condition, including people with dark skin or obesity (Demay et al., 2024). Levels vary with the season and between laboratories, and the "ideal" threshold is debated: many experts consider 50 nmol/L (20 ng/mL) enough for bone health in most people, while others aim higher.

In Belgium, the national health insurance institute (INAMI/RIZIV) reimburses the test once per calendar year. This rises to three times a year in certain situations: advanced chronic kidney disease, dialysis or kidney transplant, documented malabsorption, parathyroid disorders, phosphate diabetes or treatment with intravenous bisphosphonates (INAMI, n.d.). Testing mainly makes sense when the doctor suspects a significant deficiency or needs to monitor treatment.

Drops, tablets or ampoules: how to take it?

  • Vitamin D3 or D2? Most supplements contain D3 (cholecalciferol), which raises blood levels more effectively than plant-derived D2 (ergocalciferol).
  • With a meal. Vitamin D dissolves in fat: it is better absorbed when taken with a meal that contains a little.
  • Every day, or at longer intervals? In Belgium, 25,000 IU ampoules are very common. One ampoule a month represents about 830 IU (21 µg) a day on average, one a week about 3,600 IU (89 µg) a day, already close to EFSA's safety limit. The rhythm should therefore be the one prescribed, no more. The D-Health researchers urge caution with high monthly doses in people who are not deficient: an increase in cancer mortality appeared in exploratory analyses, which do not demonstrate cause and effect (Neale et al., 2022).
  • For how long? If you choose to take it without belonging to a risk group, the period that makes most sense is when the skin produces nothing, from October-November to March-April, at the recommended intake. For risk groups, it is up to the doctor to decide on the dose and whether to continue all year round.

Overdose and interactions

Vitamin D is stored in fat and in the liver. Taking too much for a long time can raise calcium in the blood (hypercalcaemia). This shows up as nausea, vomiting, intense thirst, confusion, kidney stones and, in severe cases, damage to the kidneys and heart (National Institutes of Health, 2026). Such poisonings remain rare. They almost always occur with very high doses taken over weeks or months, often through a dosing error or by combining products.

Some interactions are known (National Institutes of Health, 2026, for the first three):

  • orlistat, a weight-loss drug, reduces the absorption of vitamin D;
  • long-term corticosteroids reduce calcium absorption and disrupt vitamin D metabolism;
  • thiazide diuretics (often prescribed for high blood pressure) reduce the excretion of calcium by the kidneys: combined with high doses of vitamin D, they increase the risk of hypercalcaemia;
  • digoxin (a heart medicine): hypercalcaemia increases the risk of heart rhythm disorders;
  • certain anti-epileptic drugs (phenytoin, carbamazepine, phenobarbital) speed up the breakdown of vitamin D, and cholestyramine (a cholesterol-lowering drug) reduces its absorption.

Medical advice is essential before any supplementation in case of high blood calcium, recurrent kidney stones, significant kidney failure or sarcoidosis, a disease that makes the body particularly sensitive to vitamin D.

Do not combine several products containing vitamin D (ampoules, drops, multivitamins, fortified infant milk) without talking to your doctor or pharmacist.

Conclusion

In Belgium, winter really is a season without vitamin D production by the skin, and diet only partly makes up for it. For people over 70, pregnant women, children and people with little sun exposure, modest, regular supplementation during the dark months is a simple and well-supported measure. For everyone else, there is no point in pushing the dose: the large trials were clear, vitamin D is not a shield against cancer, heart disease or ageing. It remains a vitamin essential for the bones, not a longevity pill.

Disclaimer

This article is a general information summary and does not replace the advice of a doctor or pharmacist. Needs vary with age, health status and the medicines you take. Ask for advice before starting supplementation, especially during pregnancy, for a child, if you have kidney disease or if you take other treatments.

Sources

Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., Rao, S. D., Scragg, R., Tayek, J. A., Valent, A. M., Walsh, J. M. E., & McCartney, C. R. (2024). Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 109(8), 1907–1947. https://doi.org/10.1210/clinem/dgae290

EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Bohn, T., Castenmiller, J., et al. (2023). Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journal, 21(8), e08145. https://doi.org/10.2903/j.efsa.2023.8145

Hahn, J., Cook, N. R., Alexander, E. K., et al. (2022). Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ, 376, e066452. https://doi.org/10.1136/bmj-2021-066452

INAMI. (n.d.). Le remboursement du dosage de la vitamine D [Reimbursement of the vitamin D test]. https://www.inami.fgov.be/fr/faq/citoyens/le-remboursement-du-dosage-de-la-vitamine-d

Jolliffe, D. A., Camargo, C. A., Jr., Sluyter, J. D., et al. (2025). Vitamin D supplementation to prevent acute respiratory infections: Systematic review and meta-analysis of stratified aggregate data. The Lancet Diabetes & Endocrinology, 13(4), 307–320. https://doi.org/10.1016/S2213-8587(24)00348-6

LeBoff, M. S., Chou, S. H., Ratliff, K. A., et al. (2022). Supplemental vitamin D and incident fractures in midlife and older adults. The New England Journal of Medicine, 387(4), 299–309. https://doi.org/10.1056/NEJMoa2202106

Manson, J. E., Cook, N. R., Lee, I.-M., et al. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. The New England Journal of Medicine, 380(1), 33–44. https://doi.org/10.1056/NEJMoa1809944

Moreno-Reyes, R., Carpentier, Y. A., Boelaert, M., et al. (2009). Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: A cross-sectional survey in healthy adults. European Journal of Nutrition, 48(1), 31–37. https://doi.org/10.1007/s00394-008-0756-1

National Institutes of Health, Office of Dietary Supplements. (2026). Vitamin D: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

Neale, R. E., Baxter, C., Romero, B. D., et al. (2022). The D-Health Trial: A randomised controlled trial of the effect of vitamin D on mortality. The Lancet Diabetes & Endocrinology, 10(2), 120–128. https://doi.org/10.1016/S2213-8587(21)00345-4

NICE (Nutrition Information Center). (2020, November 26). Vitamine D, een wondermiddel? [Vitamin D, a miracle cure?]. https://www.nice-info.be/voedingsstoffen/vitaminen-en-mineralen/vitamine-d

Okereke, O. I., Reynolds, C. F., III, Mischoulon, D., et al. (2020). Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: A randomized clinical trial. JAMA, 324(5), 471–480. https://doi.org/10.1001/jama.2020.10224

Sciensano. (2025a). Consumption of vitamin D (National Food Consumption Survey 2022-2023). https://www.sciensano.be/en/results-national-food-consumption-survey-2022-2023/dietary-supplements/consumption-vitamin-d

Sciensano. (2025b). Vitamin D (National Food Consumption Survey 2022-2023). https://www.sciensano.be/en/results-national-food-consumption-survey-2022-2023/micronutrients-vitamins/vitamin-d

Webb, A. R., Kline, L., & Holick, M. F. (1988). Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. The Journal of Clinical Endocrinology & Metabolism, 67(2), 373–378. https://doi.org/10.1210/jcem-67-2-373

← Back to articles